Turning cost effectiveness analysis on its head

Rev Med Virol. 2019 Mar;29(2):e2040. doi: 10.1002/rmv.2040. Epub 2019 Feb 7.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Cytomegalovirus*
  • Humans
  • Pregnancy